Marc A. Cohen
2020
In 2020, Marc A. Cohen earned a total compensation of $9.1M as Interim Chief Executive Officer at C4 Therapeutics.
Compensation breakdown
| Option Awards | $9,063,399 |
|---|---|
| Other | $69,500 |
| Total | $9,132,899 |
Cohen received $9.1M in option awards, accounting for 99% of the total pay in 2020.
Cohen also received $69.5K in other compensation.
Rankings
In 2020, Marc A. Cohen's compensation ranked 964th out of 13,090 executives tracked by ExecPay. In other words, Cohen earned more than 92.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 964 out of 13,090 | 93rd |
Division Manufacturing | 339 out of 5,620 | 94th |
Major group Chemicals And Allied Products | 114 out of 2,253 | 95th |
Industry group Drugs | 100 out of 1,953 | 95th |
Industry Biological Products, Except Diagnostic Substances | 25 out of 411 | 94th |
Source: SEC filing on April 26, 2021.
Cohen's colleagues
We found five more compensation records of executives who worked with Marc A. Cohen at C4 Therapeutics in 2020.
2020
Andrew Hirsch
C4 Therapeutics
Chief Executive Officer
2020
William McKee
C4 Therapeutics
Chief Financial Officer
2020
Adam Crystal
C4 Therapeutics
Chief Medical Officer
2020
Stewart Fisher
C4 Therapeutics
Chief Scientific Officer
2020
Andrew Phillips
C4 Therapeutics